Oppenheimer’s 3Q Take on Two Banking Giants: C, JPM.
Ardelyx’s drug tenapanor gets closer to FDA approval; Cantor’s Mara Goldstein weighs in.
S3 Partners explores why bearish sentiment is not responsible for the sharp pullback in HMNY stock today.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) announced that clinical data from its IPI-549 Phase 1/1b study was selected as a late-breaking abstract and will be presented on …
Celsion Corporation (NASDAQ:CLSN) announced that it will host a Research and Development (R&D) Day for investors and analysts on Thursday, October 12, 2017. …
Helios and Matheson Analytics Inc (NASDAQ:HMNY) announced that, since August 15, 2017, it has received aggregate gross cash proceeds of approximately $12.8 million …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) saw its shares crater by as much as 62% today on exceptionally high volume. This drop was triggered by …
Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) Ortho Dermatologics division announced results from the Pivotal Phase 3 long-term extension study (AMAGINE-2), which demonstrated that SILIQ™ (brodalumab) …
Stephen Tusa trims the price target and warns that “not even a brilliant activist” can fix GE’s problems.
Here’s why Mark Mahaney “likes” Facebook better than Snap as a tech play for the near-term.
